-+ 0.00%
-+ 0.00%
-+ 0.00%

Tempest to present TPST-2003 clinical update at ISCT annual meeting

PUBT·04/29/2026 12:01:09
Listen to the news
Tempest to present TPST-2003 clinical update at ISCT annual meeting
  • Tempest to present updated clinical data on dual-targeting CD19/BCMA CAR-T candidate TPST-2003 at ISCT Scientific Annual Meeting in Dublin, May 6-9, 2026.
  • Oral presentation on REDEEM-1 Phase 1/2a trial scheduled for May 6, 2026 (12:00-13:00 GMT).
  • Poster reception for REDEEM-1 set for May 7, 2026 (18:00-19:30 GMT).


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604290800PRIMZONEFULLFEED9709257) on April 29, 2026, and is solely responsible for the information contained therein.